Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient

Kelsey E Hirotsu; Vivian Hua; Anhthy T Tran; Laura Morris; Sunil A Reddy; Bernice Y Kwong; Lisa C Zaba

doi:10.1016/j.jdcr.2021.05.005

Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient

JAAD Case Rep. 2021 May 26:13:144-146. doi: 10.1016/j.jdcr.2021.05.005. eCollection 2021 Jul.

Authors

Kelsey E Hirotsu¹, Vivian Hua¹, Anhthy T Tran¹, Laura Morris², Sunil A Reddy², Bernice Y Kwong¹, Lisa C Zaba¹

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Stanford, California.
² Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.

No abstract available

Keywords: ICI, immune checkpoint inhibitor; MCC, Merkel cell carcinoma; Merkel cell carcinoma; T-VEC, talimogene laherparepvec; cutaneous oncology; herpes; immunosuppressed; oncodermatology; talimogene laherparepvec; transplant.

Publication types

Case Reports